Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

An 84-year-old woman's hair loss was due to a rare condition called Leydig cell hyperplasia, which was treated with surgery.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

The removed ovarian tumor was a rare type of blood vessel tumor that improved the patient's symptoms and hormone levels after surgery.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

The document concludes that better biomarkers are needed to detect long-term oral testosterone use in athletes.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Finasteride is a safe, effective treatment for hirsutism with fewer side effects.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

Minoxidil helps regrow hair in female pattern hair loss, but more research needed for other treatments.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Early treatment of acne is important to prevent scarring and improve appearance, using medications that can have side effects.

Taking a small dose of prednisone before menstruation can almost completely prevent premenstrual acne with few side effects.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.